What is NDC 65145-195?

65145-195 is the product NDC for Potassium Phosphates, Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL injection, solution, concentrate, listed with the FDA by Caplin Steriles Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Potassium phosphate, Monobasic, Potassium phosphate, Dibasic.

Caplin Steriles Limited, NDC labeler code 65145. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Phosphates?

22 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Phosphates NDC 65145-195

NDC codes

FDA NDC Directory

Product NDC (as listed)65145-195Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65145-0195Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65145-195-25	6514501952565145019525	25 VIAL, SINGLE-DOSE in 1 CARTON (65145-195-25) / 15 mL in 1 VIAL, SINGLE-DOSE (65145-195-01)Marketed from Sep 17, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Phosphates
Generic name (nonproprietary): potassium phosphates
Active ingredients: Potassium phosphate, Monobasic — 224 mg/mLPotassium phosphate, Dibasic — 236 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Caplin Steriles LimitedNDC labeler code 65145
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220373
Marketing start: Sep 17, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
Identifiers: Product ID 65145-195_e6c7b072-db35-42c2-9bc2-d25cd20ca8b0SPL ID e6c7b072-db35-42c2-9bc2-d25cd20ca8b0
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465145019525 followed by a unit qualifier and the quantity

Package 65145-0195-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 65145-195

What is NDC 65145-195?: 65145-195 is the product NDC for Potassium Phosphates, Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL injection, solution, concentrate, listed with the FDA by Caplin Steriles Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Phosphates.
What is the active ingredient?: Potassium phosphate, Monobasic, Potassium phosphate, Dibasic.
Who is the labeler?: Caplin Steriles Limited, NDC labeler code 65145. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Phosphates?: 22 other product NDCs are listed under this name. See all Potassium Phosphates NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Phosphates NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-194	65145-0194-25
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-196	65145-0196-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-786	68462-0786-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-787	68462-0787-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-788	68462-0788-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Hospira, Inc.	0409-0032	00409-0032-01
Potassium Phosphates	Monobasic potassium phosphate 11.2 mg/mL; Dibasic potassium phosphate 11.8 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-656	65219-0656-10
Potassium Phosphates	Monobasic potassium phosphate 4.48 mg/mL; Dibasic potassium phosphate 4.72 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-658	65219-0658-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	InjectionIntravenous	Cipla USA Inc.	69097-055	69097-0055-97
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	InjectionIntravenous	Cipla USA Inc.	69097-077	69097-0077-97

All 23 Potassium Phosphates NDCs

Other NDCs under ANDA 220373

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220373
Product	Strength	Form · route	Labeler	Product NDC
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-194
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-196
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-786
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-787
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-788